封面
市場調查報告書
商品編碼
1650686

全球血管移植市場

Vascular Grafts

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 481 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年,全球血管移植市場將達到 59 億美元

2024 年全球血管移植市場規模估計為 39 億美元,預計到 2030 年將達到 59 億美元,2024-2030 年分析期內的複合年成長率為 7.2%。血管內動脈瘤修復 (EVAR) 適應症是報告中分析的細分市場之一,預計複合年成長率為 6.9%,到分析期結束時將達到 26 億美元。在分析期內,周邊血管修復指徵部分預計將以 8.7% 的複合年成長率成長。

美國市場規模估計為 15 億美元,中國市場預估年複合成長率為 8.9%

預計2024年美國血管移植市場規模將達15億美元。中國是世界第二大經濟體,預計到 2030 年市場規模將達到 6.876 億美元,2024-2030 年分析期間的複合年成長率為 8.9%。其他值得注意的區域市場包括日本和加拿大,預計在分析期間的複合年成長率分別為 6.5% 和 6.4%。在歐洲,預計德國的複合年成長率約為 7.1%。

全球血管移植市場 - 主要趨勢與促進因素摘要

什麼是血管移植?

血管移植是用於替換、修復或繞過體內部分血管的醫療設備,用於治療動脈硬化、動脈瘤和阻塞等疾病。這些移植物對於冠狀動脈繞道手術手術等心血管手術至關重要,可以改善心臟的血液流動。這些植入物使用的材料是根據其與人體的兼容性以及靈活性和耐用性等機械性能專門選擇的。血管移植可以由聚酯或聚四氟乙烯(PTFE)等合成材料製成,也可以由人體或動物組織修飾的生物材料製成。

科技進步如何改善血管移植技術?

血管移植技術的最新創新顯著改善了血管外科手術的結果。促進細胞增殖和再生的組織工程植入物的開發是該領域進步的一個例子。這些移植物具有高度的生物相容性,旨在促進內皮化,即移植物內表面新內皮細胞的生長,從而降低血栓症的風險並確保移植物的長期通暢性。此外,影像技術的進步提高了移植物放置的準確性,並最大限度地減少了手術期間的潛在風險和併發症。藥物釋放型移植物等技術創新有助於預防感染和血管再阻塞,使血管介入治療更有效、更安全。

血管移植在血管疾病的治療中扮演什麼角色?

血管移植在各種血管疾病的治療中起著至關重要的作用,如果不及時治療,可能會導致嚴重的併發症甚至死亡。對於患有冠狀動脈疾病的患者,可以使用血管移植來繞過阻塞的動脈並恢復心臟的正常血流。對於患有周邊動脈疾病的患者,這些移植物可以繞過腿部患病動脈,緩解疼痛和痙攣等症狀並防止截肢。對於動脈瘤,尤其是腹部主動脈血管瘤,移植物可以加強脆弱的動脈壁,防止其破裂。血管移植的多功能性和適應性使其成為血管外科手術中必不可少的工具,為高風險患者提供挽救生命的治療。

血管移植市場的成長將受到多種因素的推動

血管移植市場的成長受到多種因素的推動,包括由於人口老化導致全球心血管疾病盛行率增加以及糖尿病、肥胖症和高血壓等風險因素的增加。提高移植物功能和患者相容性的技術進步也促進了該市場的擴張。人們越來越偏好採用更小、更先進的移植物進行微創手術,以減少恢復時間並改善患者的治療效果。此外,新興國家醫療支出的增加和更先進醫療設施的出現,也擴大了血管移植手術的可近性。大眾對心血管疾病早期診斷和治療益處的認知不斷提高,進一步刺激了市場成長,並凸顯了血管移植在現代醫療實踐中的重要性。

部分

適應症(血管內動脈瘤修復 (EVAR)、周邊血管修復、血液透析機通路);原料(聚酯、ePTFE、聚氨酯、生物合成材料);最終用途(醫院、門診手術中心)

受訪公司範例(44家值得關注的公司)

  • Cardinal Health, Inc.
  • Baxter International, Inc.
  • Terumo Corporation
  • Cook Medical, LLC
  • Teleflex, Inc.
  • LeMaitre Vascular, Inc.
  • MicroPort Scientific Corporation
  • iVascular SLU
  • Jotec GmbH
  • ParaGen Technologies
  • sunnatech scientific corporation
  • Vacis
  • Cardiovascular Systems, Inc.
  • Healionics
  • InnAVasc Medical

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲國家
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP15453

Global Vascular Grafts Market to Reach US$5.9 Billion by 2030

The global market for Vascular Grafts estimated at US$3.9 Billion in the year 2024, is expected to reach US$5.9 Billion by 2030, growing at a CAGR of 7.2% over the analysis period 2024-2030. Endovascular Aneurysm Repair (EVAR) Indication, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$2.6 Billion by the end of the analysis period. Growth in the Peripheral Vascular Repair Indication segment is estimated at 8.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.5 Billion While China is Forecast to Grow at 8.9% CAGR

The Vascular Grafts market in the U.S. is estimated at US$1.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$687.6 Million by the year 2030 trailing a CAGR of 8.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.5% and 6.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.1% CAGR.

Global Vascular Grafts Market - Key Trends & Drivers Summarized

What Are Vascular Grafts, and Why Are They Critical in Modern Medicine?

Vascular grafts are medical devices used to replace, repair, or bypass sections of blood vessels in the body, often necessitated by diseases such as atherosclerosis, aneurysms, or blockages. These grafts are crucial in cardiovascular surgeries, including coronary artery bypass grafting, which helps improve blood flow to the heart. The materials used for these grafts are specifically chosen based on their compatibility with the human body and their mechanical properties, such as flexibility and durability. Vascular grafts can be made from synthetic materials like polyester and polytetrafluoroethylene (PTFE), or from biological materials, including modified human or animal tissue.

How Have Innovations Enhanced Vascular Graft Technology?

Recent innovations in vascular graft technology have significantly improved the outcomes of vascular surgeries. The development of tissue-engineering grafts, which promote cell growth and regeneration, is one example of how this field is advancing. These grafts are designed to be biocompatible and to encourage endothelialization, where new endothelial cells grow on the inner surface of the graft, thereby reducing the risk of thrombosis and ensuring the long-term patency of the graft. Additionally, advancements in imaging and diagnostic technologies have improved the precision of graft placement, minimizing risks and potential complications during surgeries. Innovations like drug-eluting grafts that help prevent infection and restenosis further enhance the efficacy and safety of vascular interventions.

What Role Do Vascular Grafts Play in Treating Vascular Diseases?

Vascular grafts play an indispensable role in the treatment of a range of vascular diseases that can lead to severe complications and even death if left untreated. In patients with coronary artery disease, vascular grafts are used to bypass clogged arteries, helping to restore normal blood flow to the heart. For individuals suffering from peripheral arterial disease, these grafts can bypass diseased arteries in the legs, alleviating symptoms like pain and cramps and preventing limb amputation. In cases of aneurysms, particularly abdominal aortic aneurysms, grafts reinforce weak arterial walls to prevent rupture. The versatility and adaptability of vascular grafts make them essential tools in vascular surgery, providing life-saving treatments for high-risk patients.

Growth in the Vascular Grafts Market Is Driven by Several Factors

The growth in the vascular grafts market is driven by several factors, including the increasing prevalence of cardiovascular diseases globally due to aging populations and rising risk factors such as diabetes, obesity, and hypertension. Technological advancements that improve graft functionality and patient compatibility also contribute to the expansion of this market. There is a growing preference for minimally invasive surgeries, which utilize smaller, more advanced grafts that reduce recovery time and improve patient outcomes. Additionally, the rise in healthcare expenditure and the availability of more sophisticated healthcare facilities in emerging economies are expanding access to vascular graft procedures. Enhanced public awareness about the benefits of early diagnosis and treatment of cardiovascular conditions further stimulates market growth, underscoring the critical nature of vascular grafts in contemporary medical practices.

SCOPE OF STUDY:

The report analyzes the Vascular Grafts market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Indication (Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair, Hemodialysis Access); Raw Material (Polyester, ePTFE, Polyurethane, Biosynthetic); End-Use (Hospitals, Ambulatory Surgical Centers)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 44 Featured) -

  • Cardinal Health, Inc.
  • Baxter International, Inc.
  • Terumo Corporation
  • Cook Medical, LLC
  • Teleflex, Inc.
  • LeMaitre Vascular, Inc.
  • MicroPort Scientific Corporation
  • iVascular S.L.U
  • Jotec GmbH
  • ParaGen Technologies
  • sunnatech scientific corporation
  • Vacis
  • Cardiovascular Systems, Inc.
  • Healionics
  • InnAVasc Medical

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Vascular Grafts - Global Key Competitors Percentage Market Share in 2024 (E)
    • A Prelude to Vascular Grafting
    • Global Market Prospects and Overview
    • Vascular Grafts Market Set for a Rapid Growth
    • Endovascular Stent-Grafts Account for Larger Share
    • Competition
    • Recent Market Activity
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Incidence of Cardio Vascular Disease Bodes Well for the Global Vascular Graft Market
    • Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
    • Global Annual Medical Cost of CVD in US$ Billion (2010-2030)
    • Rising Preference for Minimally Invasive Procedures Boosts Market Prospects
    • Rising Prevalence of Kidney Diseases Drives the Global Hemodialysis Vascular Graft Market
    • Hemodialysis Remains the Major Modality for Dialysis Treatment - A Key Opportunity
    • Global Dialysis Patient Population Distribution by Modality for Select Countries (2020): Percentage Breakdown of Hemodialysis (HD) and Peritoneal Dialysis (PD) Patients
    • Global Population of ESRD Patients Undergoing Therapy by Type of Treatment (2020): Percentage Breakdown of Patients Receiving Hemodialysis, Kidney Transplants, and Peritoneal Dialysis
    • Home Hemodialysis: A Niche Albeit High Potential Market
    • World Dialysis Clinics Market by Region (2019): Percentage Breakdown of Patients Treated by Type of Operator
    • Global Dialysis Market by Region: Percentage Breakdown of Patients Receiving Dialysis Treatment in In-Centre and Home Settings for 2019
    • Aging Population Drives Demand for Vascular Grafts
    • Increasing Healthcare Expenditure to Foster Growth
    • World Healthcare Expenditure (In US$ Trillion) for the Years 2016 & 2018
    • Rising Middle Class Population Aids Growth
    • Global Middle Class Population (in Millions) and as a Percentage of Total Population: 2005, 2015, 2025 & 2035
    • Global Middle Class Spending (in US$ Trillion) by Geographic Region
    • Risk of CAD in Obesity Offers Prospects for Coronary Stenting
    • Obesity Prevalence Rate (%) in Select Countries for the Years 2019 and 2030P
    • Cell-Free Tissue Engineered Vascular Grafts Aid in Vascular Remodeling
    • New Approach for Optimizing TEVGs
    • 3D Printed Vascular Scaffolds Hold Potential to be the New-Age TEVGs
    • A Review of Select Vascular Developments
    • Some of the important vascular innovations expected in the near-term include:
    • Offerings of Moving Analytics and Vasctrac
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair (EVAR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Endovascular Aneurysm Repair (EVAR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Endovascular Aneurysm Repair (EVAR) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Peripheral Vascular Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Peripheral Vascular Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Peripheral Vascular Repair by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Hemodialysis Access by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Hemodialysis Access by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Hemodialysis Access by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Polyester by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Polyester by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Polyester by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for ePTFE by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for ePTFE by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for ePTFE by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Polyurethane by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Polyurethane by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Polyurethane by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Biosynthetic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Biosynthetic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Biosynthetic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 24: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Ambulatory Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Ambulatory Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 27: World 15-Year Perspective for Ambulatory Surgical Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 28: World Vascular Grafts Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Vascular Grafts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Vascular Grafts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Vascular Grafts by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • JAPAN
    • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • CHINA
    • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • EUROPE
    • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Vascular Grafts by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Vascular Grafts by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Vascular Grafts by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • FRANCE
    • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • GERMANY
    • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 107: UK Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Spain 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Russia 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Vascular Grafts by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Vascular Grafts by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Vascular Grafts by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • AUSTRALIA
    • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Australia 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • INDIA
    • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 164: India Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: India 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: South Korea 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Latin America 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Vascular Grafts by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Vascular Grafts by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Vascular Grafts by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Argentina 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Brazil 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Mexico 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Rest of Latin America 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Middle East 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Vascular Grafts by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Vascular Grafts by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Vascular Grafts by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • IRAN
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Iran 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Israel 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Saudi Arabia 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: UAE 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: Rest of Middle East 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • AFRICA
    • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Africa 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030

IV. COMPETITION